首页> 外文会议>International symposium on IT in medicine and education >Chapter 66 Observation of Curative Effect on 200 Cases of Myasthenia Gravis Treated with Traditional Chinese Medicine
【24h】

Chapter 66 Observation of Curative Effect on 200 Cases of Myasthenia Gravis Treated with Traditional Chinese Medicine

机译:第66章疗效观察200例中医治疗200例

获取原文

摘要

Aim: To observe the curative effect of applying a patented traditional Chinese medicine, namely "a traditional Chinese medicine for treating myasthenia gravis" (assigned Chinese Patent of Invention in 2007), to myasthenia gravis. Methods: 200 cases of myasthenia gravis were collected during 1988-2010. One single course of treatment takes 3 months when using the above-mentioned patented medicine. Such changes of clinical symptoms are noticed before and after treatment: eyelid ptosis, diplopia, weakness, dysarthria, dysphagia, choke cough. We compile scorings according to the quantitative myasthenia gravis (QMG) score . system of Myasthenia Gravis Foundation of America. Curative effect: (1) Short-term: the shortest treatment course of this group of cases was 1 month and the longest was 30 months with an normal distribution of 7.21 ± 6.23 months. Among the 200 cases, 104 cases were fully recovered (52 %), 58 cases had obvious effect (29 %), 31 cases (15.5 %) were effective and 7 cases were ineffective (3.5 %), hence the total effective rate was 96.5 % (Table 66.1 in the text). There is a huge difference (P < 0.001, Table 66.2 in the text) between QMG scores of various symptoms before and after treatment (paired-t test). (2) Long-term curative effect: through following up part of the recovered patients (24 cases) for at least half a year and at most 19 years with an average period of 5.72 years, the patients can still participate in normal work or housework without recurrence. Conclusion: The curative effect of 200 cases of myasthenia gravis treated by this patent traditional Chinese medicine was satisfied during 1988-2010.
机译:目的:观察应用专利中药应用的疗效,即“一种用于治疗肌无力治疗肌无力的中药”(2007年在2007年分配发明专利),对Myasthenia Gravis进行了肌瘤。方法:在1988 - 2010年期间收集了200例Myasthenia肌炎病例。使用上述专利药物时,单一的治疗过程需要3个月。在治疗前后注意到临床症状的这种变化:眼睑皮瓣,复源性,无力,脱泻,吞咽困难,窒息咳嗽。我们根据定量肌肌肌瘤(QMG)评分编制盗痕。美国肌无力岩石基金会。疗效:(1)短期:这组病例的最短治疗过程为1个月,最长为30个月,正常分布为7.21±6.23个月。在200例中,104例完全恢复(52%),58例效果明显(29%),31例(15.5%)有效,7例无效(3.5%),因此总有效率为96.5 %(文本中的表66.1)。在治疗之前和之后的各种症状的QMG评分之间存在巨大的差异(P <0.001,表66.2),治疗前后的各种症状(配对T测试)。 (2)长期疗效:通过追随部分恢复的患者(24例)至少有半年,最多19年平均为5.72岁,患者仍然可以参加正常的工作或家务没有复发。结论:1988 - 2010年,该专利中医治疗200例肌炎肌无力200例的疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号